Sedating Rx Drug Warnings Should Be Federally Mandated, NABP Says
Executive Summary
Federally mandated warning labels on packaging regarding the potential sedation effects of certain prescription and OTC drugs would be supported by the National Association of Boards of Pharmacy, NABP consultant Jon May stated
You may also be interested in...
Allegra “Drives On” With Physician Campaign Ahead Of Claritin OTC Switch
Aventis will not change its marketing strategy for Allegra following the departure of Schering-Plough's Claritin from the prescription antihistamine market
Allegra “Drives On” With Physician Campaign Ahead Of Claritin OTC Switch
Aventis will not change its marketing strategy for Allegra following the departure of Schering-Plough's Claritin from the prescription antihistamine market
“Cognitively Accessible” Rx Labeling Tested By FDA Risk Cmte. Member Day
"Cognitively accessible" prescription drug labeling could reduce medical errors by as much as 80%, according to a forthcoming study by FDA drug safety advisory committee member Ruth Day, PhD